checkpoint inhibitors

Merck Wins FDA Approval for Subcutaneous Keytruda as Exclusivity Challenges Approach

3 months ago talkbio0Tagged Approved, Biosimilars, checkpoint inhibitors, Immunotherapy for cancer, Keytruda, Keytruda Qlex, Merck, patent expiration, Solid Neoplasm, Subcutaneous Injections, United States Food and Drug Administration

Merck; Keytruda; subcutaneous injection; FDA approval; Keytruda Qlex; patent expiration; biosimilars; checkpoint inhibitors; solid tumors; cancer immunotherapy

Scancell’s Cancer Vaccine Supercharges Melanoma Immunotherapy in Recent Trials

5 months ago talkbio0Tagged Cancer Vaccines, checkpoint inhibitors, Clinical Trials, Immunotherapy, iSCIB1 +, melanoma, Melanoma TRP2 CTL Epitope Vaccine SCIB1, Scancell, SCOPE trial

Scancell; SCIB1; iSCIB1+; melanoma; cancer vaccine; immunotherapy; checkpoint inhibitors; clinical trial; SCOPE trial

A Decade of Progress: Immuno-oncology on the Cusp of a New Era

1 year ago talkbio0Tagged Antibodies, Bispecific, cancer care, Cancer Research, Cancer Therapeutic Procedure, checkpoint inhibitors, immuno-oncology, Immunotherapy

Immuno-oncology, checkpoint inhibitors, bispecific antibodies, cancer treatment, immunotherapy, cancer research, future of cancer care.

FDA to Reassess Checkpoint Inhibitors for Stomach Cancer Based on PD-L1 Expression

1 year ago talkbio0Tagged Advisory Committees, checkpoint inhibitors, Gene Expression, Oncologic, PD-L1, United States Food and Drug Administration

FDA, checkpoint inhibitors, stomach cancer, PD-L1 expression, Oncologic Drugs Advisory Committee